The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Inflammatory Bowel Diseases

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Inflammatory Bowel Diseases


Psychiatry related information on Inflammatory Bowel Diseases


High impact information on Inflammatory Bowel Diseases


Chemical compound and disease context of Inflammatory Bowel Diseases


Biological context of Inflammatory Bowel Diseases


Anatomical context of Inflammatory Bowel Diseases


Gene context of Inflammatory Bowel Diseases


Analytical, diagnostic and therapeutic context of Inflammatory Bowel Diseases


  1. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. Schottenfeld, D., Beebe-Dimmer, J. CA: a cancer journal for clinicians. (2006) [Pubmed]
  2. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. Schreiber, S., Howaldt, S., Schnoor, M., Nikolaus, S., Bauditz, J., Gasché, C., Lochs, H., Raedler, A. N. Engl. J. Med. (1996) [Pubmed]
  3. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. Neurath, M.F., Fuss, I., Kelsall, B.L., Presky, D.H., Waegell, W., Strober, W. J. Exp. Med. (1996) [Pubmed]
  4. Tissue-specific gene expression results from a purine- and pyrimidine-free diet and 6-mercaptopurine in the rat small intestine and colon. Leleiko, N.S., Martin, B.A., Walsh, M., Kazlow, P., Rabinowitz, S., Sterling, K. Gastroenterology (1987) [Pubmed]
  5. Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease: a possible consequence of lithocholate toxicity. Fouin-Fortunet, H., Le Quernec, L., Erlinger, S., Lerebours, E., Colin, R. Gastroenterology (1982) [Pubmed]
  6. Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases. Takano, H., Hasegawa, H., Zou, Y., Komuro, I. Curr. Pharm. Des. (2004) [Pubmed]
  7. Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease. Lindsey, I., George, B., Kettlewell, M., Mortensen, N. Dis. Colon Rectum (2002) [Pubmed]
  8. Psychosocial morbidity of Graves' orbitopathy. Kahaly, G.J., Petrak, F., Hardt, J., Pitz, S., Egle, U.T. Clin. Endocrinol. (Oxf) (2005) [Pubmed]
  9. Genetic basis of schizophrenia: trinucleotide repeats. An update. Vaswani, M., Kapur, S. Prog. Neuropsychopharmacol. Biol. Psychiatry (2001) [Pubmed]
  10. Genetic variation in DLG5 is associated with inflammatory bowel disease. Stoll, M., Corneliussen, B., Costello, C.M., Waetzig, G.H., Mellgard, B., Koch, W.A., Rosenstiel, P., Albrecht, M., Croucher, P.J., Seegert, D., Nikolaus, S., Hampe, J., Lengauer, T., Pierrou, S., Foelsch, U.R., Mathew, C.G., Lagerstrom-Fermer, M., Schreiber, S. Nat. Genet. (2004) [Pubmed]
  11. Recombinant erythropoietin for anemia in inflammatory bowel disease. Fischer, T. N. Engl. J. Med. (1996) [Pubmed]
  12. Cyclosporine therapy for inflammatory bowel disease. Sartor, R.B. N. Engl. J. Med. (1994) [Pubmed]
  13. Folate levels in inflammatory bowel disease. Longstreth, G.F., Green, R. N. Engl. J. Med. (1982) [Pubmed]
  14. Serum gastrin in inflammatory bowel disease. Spence, R.A., Buchanan, K.D. N. Engl. J. Med. (1982) [Pubmed]
  15. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. Klotz, U., Maier, K., Fischer, C., Heinkel, K. N. Engl. J. Med. (1980) [Pubmed]
  16. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. Rousseaux, C., Lefebvre, B., Dubuquoy, L., Lefebvre, P., Romano, O., Auwerx, J., Metzger, D., Wahli, W., Desvergne, B., Naccari, G.C., Chavatte, P., Farce, A., Bulois, P., Cortot, A., Colombel, J.F., Desreumaux, P. J. Exp. Med. (2005) [Pubmed]
  17. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. Li, C., Dandridge, K.S., Di, A., Marrs, K.L., Harris, E.L., Roy, K., Jackson, J.S., Makarova, N.V., Fujiwara, Y., Farrar, P.L., Nelson, D.J., Tigyi, G.J., Naren, A.P. J. Exp. Med. (2005) [Pubmed]
  18. Composition of human colonic mucin. Selective alteration in inflammatory bowel disease. Podolsky, D.K., Isselbacher, K.J. J. Clin. Invest. (1983) [Pubmed]
  19. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Connell, W.R., Kamm, M.A., Dickson, M., Balkwill, A.M., Ritchie, J.K., Lennard-Jones, J.E. Lancet (1994) [Pubmed]
  20. Safety of azathioprine in pregnancy in inflammatory bowel disease. Alstead, E.M., Ritchie, J.K., Lennard-Jones, J.E., Farthing, M.J., Clark, M.L. Gastroenterology (1990) [Pubmed]
  21. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Berg, D.J., Zhang, J., Weinstock, J.V., Ismail, H.F., Earle, K.A., Alila, H., Pamukcu, R., Moore, S., Lynch, R.G. Gastroenterology (2002) [Pubmed]
  22. Polyethylene glycol 400 penetration of the colonic epithelial barrier of the rat. Krugliak, P., Hollander, D., Schlaepfer, C.C., Katz, K.D., Dadufalza, V.D., Ma, T.Y. Gastroenterology (1990) [Pubmed]
  23. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Dubinsky, M.C., Lamothe, S., Yang, H.Y., Targan, S.R., Sinnett, D., Théorêt, Y., Seidman, E.G. Gastroenterology (2000) [Pubmed]
  24. High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis. Murch, S.H., Braegger, C.P., Sessa, W.C., MacDonald, T.T. Lancet (1992) [Pubmed]
  25. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. Monteleone, G., Kumberova, A., Croft, N.M., McKenzie, C., Steer, H.W., MacDonald, T.T. J. Clin. Invest. (2001) [Pubmed]
  26. Inflammatory bowel disease reveals the kinase activity of KSR1. Kolesnick, R., Xing, H.R. J. Clin. Invest. (2004) [Pubmed]
  27. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Sharon, P., Stenson, W.F. Gastroenterology (1984) [Pubmed]
  28. Monoclonal B lymphocytes in the peripheral blood of patients with inflammatory bowel disease. Ginsburg, C.H., Ault, K.A., Falchuk, Z.M. Gastroenterology (1981) [Pubmed]
  29. Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine. Sandoval, M., Liu, X., Mannick, E.E., Clark, D.A., Miller, M.J. Gastroenterology (1997) [Pubmed]
  30. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. Davidson, N.J., Leach, M.W., Fort, M.M., Thompson-Snipes, L., Kühn, R., Müller, W., Berg, D.J., Rennick, D.M. J. Exp. Med. (1996) [Pubmed]
  31. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Schreiber, S., Heinig, T., Thiele, H.G., Raedler, A. Gastroenterology (1995) [Pubmed]
  32. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Vermeire, S., Pierik, M., Hlavaty, T., Claessens, G., van Schuerbeeck, N., Joossens, S., Ferrante, M., Henckaerts, L., Bueno de Mesquita, M., Vlietinck, R., Rutgeerts, P. Gastroenterology (2005) [Pubmed]
  33. Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell line. Kaiser, G.C., Polk, D.B. Gastroenterology (1997) [Pubmed]
  34. Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity. West, G.A., Matsuura, T., Levine, A.D., Klein, J.S., Fiocchi, C. Gastroenterology (1996) [Pubmed]
  35. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., Remaut, E. Science (2000) [Pubmed]
  36. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Blumberg, R.S., Saubermann, L.J., Strober, W. Curr. Opin. Immunol. (1999) [Pubmed]
  37. Total parenteral nutrition and bowel rest in inflammatory bowel disease. Weser, E. Gastroenterology (1980) [Pubmed]
  38. Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice. Mizoguchi, E., Mizoguchi, A., Takedatsu, H., Cario, E., de Jong, Y.P., Ooi, C.J., Xavier, R.J., Terhorst, C., Podolsky, D.K., Bhan, A.K. Gastroenterology (2002) [Pubmed]
  39. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Sakai, T., Kusugami, K., Nishimura, H., Ando, T., Yamaguchi, T., Ohsuga, M., Ina, K., Enomoto, A., Kimura, Y., Yoshikai, Y. Gastroenterology (1998) [Pubmed]
WikiGenes - Universities